immunogen inc (IMGN:NASDAQ GS)
Gregory D. Perry
Chief Financial & Business Officer and Principal Accounting Officer, Eleven Biotherapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 21 board members in 2 different organizations across 11 different industries.|
See Board Relationships
Mr. Gregory D. Perry, also known as Greg, has been Chief Financial & Business Officer and Principal Accounting Officer at Eleven Biotherapeutics, Inc. since December 2013. Mr. Perry served as an Interim Chief Financial Officer of InVivo Therapeutics Holdings Corp. from September 23, 2013 to December 30, 2013. He served as the Chief Financial Officer of ImmunoGen, Inc. from 2009 to September 13, 2013 and served as its Executive Vice President from April 2011 to September ...
830 Winter StreetPhone: 781-895-0600
Waltham, Massachusetts 02451
Board Members Memberships*
Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Director, Chairman of Audit Committee and Member of Compensation Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|